TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/24/23 11:00 | 4/20/23 | CYTH | Cyclo Therapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Tate Jeffrey | FL | DO | COO | P.d | 21 | 0.7100 | 0 | 30 | 93 | 62 | D | ||||||||||||||
5/16/22 13:01 | 5/16/22 | CYTH | Cyclo Therapeutics, Inc. | FL | Chem | OChm | Industrial Organic Chemicals | Tate Jeffrey | FL | DO | COO | P | 6 | 2.12 | 0 | 3 | 10 | 32 | D | ||||||||||||||
4/29/22 15:36 | 4/28/22 | CYTH | Cyclo Therapeutics, Inc. | FL | Chem | OChm | Industrial Organic Chemicals | Tate Jeffrey | FL | DO | COO | P.m | 5 | 2.64 | 0 | 2 | 7 | 29 | D | ||||||||||||||
3/30/21 13:24 | 3/29/21 | CYTH | Cyclo Therapeutics, Inc. | FL | Chem | OChm | Industrial Organic Chemicals | Tate Jeffrey | FL | DO | COO | P | 15 | 7.50 | 0 | 2 | 8 | 27 | D | ||||||||||||||
12/26/18 18:39 | 12/26/18 | CTDH | Ctd Holdings Inc | FL | Chem | OChm | Industrial Organic Chemicals | Tate Jeffrey | FL | DO | COO,Chie | P.d | 0 | 0.00 | 0 | 25 | 3 | 866 | D | ||||||||||||||
6/8/16 16:11 | 6/6/16 | CTDH | Ctd Holdings Inc | FL | Chem | OChm | Industrial Organic Chemicals | Tate Jeffrey | FL | DO | COO,CSO | P.d | 0 | 0.00 | 0 | 100 | 18 | 661 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |